Mark Dredze

These Travel Influencers Don’t Want Freebies. They’re A.I.

This NYT story about A.I. travel avatars is being treated as a novelty. “Synthetic influencers are here!”
But the underlying platform architecture is the same. What’s changing is how efficiently actors can exploit it.

A.I. influencers simply remove the human bottlenecks.

Fantastic talk by Hopkins Medicine's Peter Najjar at the @jhumceh.bsky.social symposium on Human + AI to redefine the standard of care in medicine.

What can AI do to improve quality and safety in medicine?

Loving the “Pitch a problem” session at the Johns Hopkins Symposium on Engineering in Healthcare. Lots of animated conversations! @jhumceh.bsky.social

Mark Dredze named director of Johns Hopkins Data Science and AI Institute Dredze, a member of JHU’s faculty since 2009, has been selected to lead the university institute dedicated to harnessing the power of AI to translate data-driven discovery into real-world impact.

Congratulations again to John C. Malone Professor of Computer Science @mdredze.bsky.social on this accomplishment!

Headshots of Mark Dredze, Jason Eisner, Peter Kazanzides, and Tom Lippincott.

Congratulations to CS faculty @mdredze.bsky.social, Jason Eisner, Peter Kazanzides, and @tom-lippincott.bsky.social
on their @jhu.edu Nexus Awards! Learn more about their funded projects here: www.cs.jhu.edu/news/compute...

🚨 You are only evaluating a slice of your test-time scaling model's performance! 🚨

📈 We consider how models’ confidence in their answers changes as test-time compute increases. Reasoning longer helps models answer more confidently!

📝: arxiv.org/abs/2502.13962

David Broniatowski on LinkedIn: NIH has just announced that it will save $4 billion by capping university… | 61 comments NIH has just announced that it will save $4 billion by capping university indirect costs on federal grants. Will this actually save money? Bottom line: No. It… | 61 comments on LinkedIn

Please read and share this excellent FAQ on University indirect costs by my friend @broniatowski.bsky.social

He explains why these funds are essential and a critical investment for research in the United States.

www.linkedin.com/posts/david-...

I know I can improve my ARR reviews, but there really is no need for name calling. 😁

Helpful
Insightful
Probing
Valuable
Thoughtful
Illuminating
Constructive

In author feedback, these are synonyms for "we hate your review."

Do reviewers purposely write confusing reviews with typos to demonstrate that the review wasn't written by a LLM?

Golden idea for an NLP paper: a group of llamas is called a "cria herd".

That would make a great name for a LLM method, model, or paper.

Just remember to acknowledge me in your paper.

You're welcome.

Idea for GenAI app: rewrite click bait headlines to normal headlines in the browser.

Input: you’ll never guess this one company organizing the best deals of the year

Output: Amazon has a modest sale on phone chargers

Good idea!

The ARR submission checklist is already pretty extensive, but I suggest we add an additional question:

"I certify that I know the difference between \citet and \citep."

ARR: Reviews are due today.

Me:

I feel seen. This is why I always access my API keys from my laptop.

Do you have any of those fortune cookies that mock academics?

Sure!

Starting a new year and reflecting on how lucky I am to work at @hopkinsengineer.bsky.social with amazing people @jhucompsci.bsky.social @jhuclsp.bsky.social.

I was promoted to full professor in 2023, and my students presented me with this amazing poster of current and former PhD students.

AI Ethics and Safety — A Contradiction in Terms? Podcast Episode · On with Kara Swisher · 01/02/2025 · 53m

Listen to @karaswisher.bsky.social's new podcast where she interviews @ruchowdh.bsky.social, @ghadfield.bsky.social and me about AI Ethics and Safety. The podcast was recorded before a live audience at @jhu.edu Bloomberg Center.

podcasts.apple.com/us/podcast/a...

Examining the generated QA pairs, you can really see the difference. Our generations (bottom) look harder and more interesting.

Try our strategy for your synthetic generation task? Check out our paper, being presented at #ML4H2024 .
arxiv.org/abs/2412.04573

Training a Clinical QA system on our data gives big improvements, whether we generate data from Llama or GPT-4o. These improvements are both in F1 and any overlap between the extracted and true answers.

The generated pair has a lot of advantages: it doesn't use the same language as the report, it includes harder questions, and the answers are sometimes not in the report (unanswerable questions.) The result? Harder, more diverse and more realistic QA pairs.

Second, we use a summarize-then-generate strategy. The LLM first summarizes a given clinical record in a structured format. The summary keeps the key points but loses the details, such as specific terminology and content. We then use the summary to generate a new QA pair.

We explore two strategies. First, we craft instructions to encourage QA diversity. We formulate these as constraints on the answers to the questions. It helps, but we need more.

We can ask an LLM to write QA pairs, but they turn out to be too easy and repetitive. They don't come close to what you can get with real data. We need more diverse data! Typical methods (e.g. annealing) don't work. What can we do?

Paper at #ML42024!

Clinical QA can help doctors find critical information in patient records. But where do we get training data for these systems? Generating this data from an LLM is hard. 🧵

Are Clinical T5 Models Better for Clinical Text? Large language models with a transformer-based encoder/decoder architecture, such as T5, have become standard platforms for supervised tasks. To bring these technologies to the clinical domain, recent...

Takeaways: If you can fine-tune a model on a specific clinical domain, that's great. If you can't, you should probably use models that are better overall, even if they aren't trained on clinical data.

Many more details in the paper!
arxiv.org/abs/2412.05845

It turns out that when you have just a little supervised data, the models trained on more data and tasks, even when out of domain, do BETTER on the new clinical domain.

Maybe the real advantage for domain-tuned models lies in the low resource setting. With lots of supervised data, an out of domain model can do well. What about with just a few training examples?

We try a new clinical task and dataset/domain. In this case, the clinical T5 benefits disappear.